Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | CES1 | P23141 | 6/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL959689 | 0.92 | CES2 (0.56) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL13717050 | 0.90 | CES2 (0.59) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL4077269 | 0.90 | CES2 (0.59) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL866970 | 0.82 | — | — | |
| SCHEMBL15402656 | 0.74 | — | — | |
| SCHEMBL8436421 | 0.74 | CES2 (0.43) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL12396593 | 0.74 | CES2 (0.54) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL1706449 | 0.74 | CES2 (0.54) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL27956206 | 0.74 | CES2 (0.34) | CES2LPAR1LPAR3FAAHCES1 | |
| SCHEMBL23825120 | 0.72 | CES2 (0.41) | CES2LPAR1LPAR3FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110650947-B | Methods and molecules | 免疫医疗有限责任公司 | 2023-05-12 | — | — | CN | claimed |
| US-20210283141-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LIMITED (GB) | 2021-09-16 | — | — | US | claimed |
| EP-3801630-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LIMITED (GB) | 2021-04-14 | — | — | EP | claimed |
| CN-112203696-A | Pyrrolobenzodiazepine conjugates | 免疫医疗有限公司 | 2021-01-08 | — | — | CN | claimed |
| CN-110650947-A | Methods and molecules | 免疫医疗有限责任公司 | 2020-01-03 | — | — | CN | claimed |
| WO-2019224340-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LIMITED (GB) | 2019-11-28 | — | — | WO | claimed |
| CN-107209146-B | Electrochemical gas sensor and electrolyte for electrochemical gas sensor | 德尔格安全股份两合公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20230321267-A1 | Method And Molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
| WO-2023174773-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2023-09-21 | — | — | WO | disclosed |
| US-11759526-B2 | Method and molecules | MEDIMMUNE, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| EP-4223319-A2 | METHOD AND MOLECULES | MedImmune, LLC (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-3630732-B1 | METHOD AND MOLECULES | MEDIMMUNE LLC (US) | 2023-07-12 | — | — | EP | disclosed |
| CN-110650947-B | Methods and molecules | 免疫医疗有限责任公司 | 2023-05-12 | — | — | CN | disclosed |
| EP-1801097-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-06-27 | — | — | EP | disclosed |
| US-7217492-B2 | Onium salt compound and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2007-05-15 | — | — | US | disclosed |
| US-7210763-B2 | Inkjet recording head and inkjet recording device | FUJIFILM CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
| US-20050068367-A1 | Inkjet recording head and inkjet recording device | FUJI PHOTO FILM CO., LTD. (JP) | 2005-03-31 | — | — | US | disclosed |
| US-20050062801-A1 | Inkjet recording head and inkjet recording device | FUJI PHOTO FILM CO., LTD. (JP) | 2005-03-24 | — | — | US | disclosed |
| US-20050053861-A1 | Onium salt compound and radiation-sensitive resin composition | JSR CORPORATION (JP) | 2005-03-10 | — | — | US | disclosed |
| US-3978079-A | DIPHTHALIMIDO, DISUCCINIMIDO AND DIMALEIMIDO OXALATES | AMERICAN CYANAMID COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321267-A1 | Method And Molecules | PAICS, EPCAM, SQLE | CES2 90/4885LPAR1 402/4885LPAR3 356/4885 |
| US-11759526-B2 | Method and molecules | PAICS, EPCAM, SQLE | CES2 90/4885LPAR1 402/4885LPAR3 356/4885 |
| US-20210283141-A1 | PYRROLOBENZODIAZEPINE CONJUGATES | LANCL1, CD79B, FCGR2A | CES2 1492/4885LPAR1 1588/4885LPAR3 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.